UCB S.A. of SMYRNA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-13. The offering totals $788K, of which $788K was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Kay Davies | Director | Brussels, C9 |
| Albrecht De Graeve | Director | Brussels, C9 |
| Arnoud de Pret | Director | Brussels, C9 |
| Evelyn du Monceau | Director | Brussels, C9 |
| Harriet Edelman | Director | Union, NJ |
| Charles-Antoine Janssen | Director | Brussels, C9 |
| Jean-Pierre Kinet | Director | Paris, I0 |
| Gerhard Mayr | Director | Brussels, C9 |
| Tom McKillop | Director | Brussels, C9 |
| Norman Orstein | Director | Brussels, C9 |
| Jean-Christophe Tellier | Director | Brussels, C9 |
| Cedric van Rijckevorsel | Director | Brussels, C9 |
| Ctesse du Monceau de Bergendal | Executive Officer | Brussels, C9 |
| Gerhard Mayr | Executive Officer | Brussels, C9 |
| Jean-Christophe Tellier | Executive Officer | Brussels, C9 |
| Jeffrey Wren | Executive Officer | Brussels, C9 |
| Michel Xavier | Executive Officer | Brussels, C9 |